Association Between Acute Statin Therapy, Survival, and Improved Functional Outcome After Ischemic Stroke: The North Dublin Population Stroke Study
暂无分享,去创建一个
L. Daly | P. Kelly | E. Williams | L. Kyne | M. Marnane | Á. Merwick | O. Sheehan | N. Hannon | T. Grant | J. Moroney | P. Mccormack | J. Duggan | D. Harris | G. Horgan | D. Ní Chróinín | E. Callaly | David Williams | P. McCormack
[1] M. Reeves. Letter by Reeves regarding article, "association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the north dublin population stroke study". , 2011, Stroke.
[2] K. Furie,et al. Statin Treatment and Functional Outcome After Ischemic Stroke: Case–Control and Meta-Analysis , 2011, Stroke.
[3] Gustavo Saposnik,et al. IScore: A Risk Score to Predict Death Early After Hospitalization for an Acute Ischemic Stroke , 2011, Circulation.
[4] P. Kelly,et al. Stroke Subtype Classification to Mechanism-Specific and Undetermined Categories by TOAST, A-S-C-O, and Causative Classification System: Direct Comparison in the North Dublin Population Stroke Study , 2010, Stroke.
[5] J. Broderick,et al. Stroke Incidence Is Decreasing in Whites But Not in Blacks: A Population-Based Estimate of Temporal Trends in Stroke Incidence From the Greater Cincinnati/Northern Kentucky Stroke Study , 2010, Stroke.
[6] M. Hennerici,et al. Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial , 2009, Stroke.
[7] Alex J Sutton,et al. Statins for the prevention and treatment of infections: a systematic review and meta-analysis. , 2009, Archives of internal medicine.
[8] R. Sacco,et al. High-Dose Lovastatin for Acute Ischemic Stroke: Results of the Phase I Dose Escalation Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART) , 2009, Cerebrovascular Diseases.
[9] Robert D. Brown,et al. Statins in ischemic stroke: just low-density lipoprotein lowering or more? , 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[10] S. Schwab,et al. Neuroprotection by pravastatin in acute ischemic stroke in rats , 2008, Brain Research Reviews.
[11] J. Gargano,et al. Effect of Pretreatment With Statins on Ischemic Stroke Outcomes , 2008, Stroke.
[12] L. Mascitelli,et al. STATIN TREATMENT WITHDRAWAL IN ISCHEMIC STROKE: A CONTROLLED RANDOMIZED STUDY , 2008, Neurology.
[13] C. Molina,et al. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial , 2007, European journal of neurology.
[14] F. F. B. YANIKa,et al. Hypertriglyceridemia-Induced Acute Pancreatitis During Pregnancy: Editorial Comment , 2018 .
[15] A. Demchuk,et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial , 2007, The Lancet Neurology.
[16] M. A. Moro,et al. Statin treatment withdrawal in ischemic stroke , 2007, Neurology.
[17] T. Dalkara,et al. Statin pre-treatment protects brain against focal cerebral ischemia in diabetic mice. , 2007, The Journal of surgical research.
[18] W. Howard. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2007 .
[19] J. Farmer. High-dose atorvastatin after stroke or transient ischemic attack. , 2007, Current atherosclerosis reports.
[20] M. Hennerici,et al. High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.
[21] R. Califf,et al. Statin Use and Sex-Specific Stroke Outcomes in Patients With Vascular Disease , 2006, Stroke.
[22] S. Gutnikov,et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) , 2005, The Lancet.
[23] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[24] E. Tremoli,et al. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. , 2005, Neurotoxicology.
[25] R. Sacco,et al. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality , 2005, Neurology.
[26] K. Lees,et al. Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment–control study , 2005, European journal of neurology.
[27] M. Fisher,et al. HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcome , 2005, Stroke.
[28] V. Feigin,et al. Editorial comment--Stroke incidence studies one step closer to the elusive gold standard? , 2004, Stroke.
[29] J. Martí-Fàbregas,et al. Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins , 2004, Stroke.
[30] S. Warach,et al. Rising statin use and effect on ischemic stroke outcome , 2004, BMC medicine.
[31] Yi Li,et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke , 2003, Annals of neurology.
[32] E. Tremoli,et al. Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[33] K. Hirata,et al. HMG-CoA Reductase Inhibitor Has Protective Effects Against Stroke Events in Stroke-Prone Spontaneously Hypertensive Rats , 2003, Stroke.
[34] R. de Caterina,et al. Statins and stroke: evidence for cholesterol-independent effects , 2002 .
[35] M. Moskowitz,et al. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. , 2001, Stroke.
[36] B. Psaty,et al. Assessment and Control for Confounding by Indication in Observational Studies , 1999, Journal of the American Geriatrics Society.
[37] M. Moskowitz,et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.